DSM’s lactose-free dairy ingredient Maxilact has been granted a European patent - giving the company exclusive permission to market "clean taste" arylsulfatase-free lactase enzymes in the region until 2026.
Sales of lactose-free dairy products have doubled over the last five years, with an increase in self-diagnosed cases of lactose intolerance in the US and Europe driving $900m sales.